3514 results for «2030»
3514 results
Coronary drug-coated balloons - Why, when and how
23 May 2019 – From EuroPCR 2019
Consult this session to discover practical tips about coronary drug-coated balloon, and learn more about its use, where it may provide a clinical benefit, and more!
Reducing long term ischaemic events in high-risk patients: the role of intensified antithrombotic treatment
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of intensified antithrombotic treatment in improving cardiovascular outcomes in high-risk patients and how to implement this treatment.
Ability to treat diabetic patients: DES + DCB strategy
23 May 2019 – From EuroPCR 2019
Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.
Update on management of complex calcified coronary lesions
23 May 2019 – From EuroPCR 2019
Consult this session to discover updates on the management of complex calcified coronary lesions, to better understand which cases may be almost impossible to stent, to learn techniques to make stenting possible, and more!
RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system in a randomised, blinded, sham-controlled study
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest results from the RADIANCE-HTN SOLO cohort at the 6-month time point to assess efficacy of renal denervation in patients after medication titration.
Precision meets simplicity – Complex PCI guided by a 2nd generation fibre optic physiology guidewire
23 May 2019 – From EuroPCR 2019
Consult this session to learn through various compelling clinical cases how the new OptoWire physiology guidewire can make the difference compared to the current pressurewires, and how to use it in bifurcations, serial lesions and CAD and aortic stenoses.
Emerging transcatheter-based interventions for volume management in advanced heart failure
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about emerging device-based approach in heart failure with preserved ejection fraction, the devices specifics and how to use them, and more!
What's new in hypertension treatment – An update for interventionists
23 May 2019 – From EuroPCR 2019
Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!
Latest developments in cerebral embolic protection
23 May 2019 – From EuroPCR 2019
Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.
LIVE demonstration from Clinique Pasteur - Toulouse, France: Complex aortoiliac bifurcation treatment
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.
Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond
23 May 2019 – From EuroPCR 2019
Consult this session on innovations in complex multivessel disease PCI to learn more about the recent innovations in physiology and IVUS guidance and to review current data on rotational atherectomy for calcified lesion preparation.
Complex PCI in high bleeding risk patients
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.
TAVI outcomes outside the cathlab – Importance of haemodynamics and durability
23 May 2019 – From EuroPCR 2019
Watch this LIVE case to learn more on TAVI in failed surgical aortic bioprosthesis, how to minimise risk of patient-prosthesis mismatch and coronary protection.
A 91-year-old female with an active lifestyle underwent a surgical aortic valve replacement 15 years ago. She presents with NYHA III and CCS...
New trials in coronary imaging and physiology
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!
Exploring evidence and experience with magnesium scaffold Magmaris
23 May 2019 – From EuroPCR 2019
Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.
PCI complications in daily practice: patient, device or doctor?
23 May 2019 – From EuroPCR 2019
Consult this session on PCI complications in daily practice and learn through compelling cases all about the successful and unsuccessful steps taken to solve adverse events.
Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions
23 May 2019 – From EuroPCR 2019
Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.
ON MED, OFF MED, now what? Future of renal denervation
23 May 2019 – From EuroPCR 2019
Consult this session on renal denervation to gain insights on the future of renal denervation and to learn about the latest results of SPYRAL HTN clinical program.
Nightmare complications of left main PCI
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to anticipate and prevent severe left main complications and how to successfully manage left main complications such as dissection, perforation and stent loss.
Optimising anticoagulation management in atrial fibrillation: focus on patients with concomitant ACS and/or undergoing PCI
22 May 2019 – From EuroPCR 2019
Consult this session to learn about the current evidence in managing atrial fibrillation patients with concomitant acute coronary syndrome (ACS) and/or undergoing PCI, and to review the role of non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin for atrial fibrillation (AF).
